Standard BioTools Inc.

LAB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $58.1M $35.0M $29.1M $33.7M $35.3M $58.6M $13.6M $5.7M
Accounts Receivable $15.0M $14.6M $25.5M $22.4M $10.6M $12.9M $9.3M $8.1M
Inventory $15.1M $20.1M $17.9M $16.0M $8.1M $7.2M $6.0M $4.9M
Total Current Assets $94.8M $96.7M $144.1M $155.9M $104.6M $101.2M $70.0M $20.9M
Property, Plant & Equipment $12.3M $16.5M $15.3M $13.9M $6.8M $5.0M $3.3M $2.3M
Goodwill $104.1M $104.1M $104.1M $104.1M $0
Intangible Assets (Excl. Goodwill) $68.6M $79.8M $91.0M $102.2M $0
Total Assets $287.4M $306.4M $370.1M $407.6M $116.9M $113.7M $79.3M $24.8M
Liabilities
Accounts Payable $4.2M $4.0M $6.1M $5.9M $4.4M $2.6M $4.0M $3.2M
Total Current Liabilities $33.5M $29.5M $30.1M $29.4M $18.0M $11.6M $20.2M $18.5M
Long-Term Debt $0 $1.2M $10.1M
Total Liabilities $256.4M $253.2M $255.1M $257.1M $20.5M $13.1M $22.4M $29.4M
Stockholders' Equity
Retained Earnings $-500.2M $-439.5M $-363.5M $-310.2M $-257.3M $-240.8M $-221.8M $-199.3M
Total Stockholders' Equity $30.9M $53.2M $114.9M $150.4M $96.4M $100.7M $56.9M $-189.2M
← Newer Page 2 of 3 Older →